Lexicon Pharmaceuticals (LXRX) Change in Inventory (2017 - 2026)
Lexicon Pharmaceuticals (LXRX) posted quarterly Change in Inventory of -$5000.0 for Q1 2026, up 83.33% year-over-year from -$2727.3 in Q1 2025, and down 104.07% quarter-over-quarter from $123000.0 in Q4 2025.
Lexicon Pharmaceuticals (LXRX) Change in Inventory (2017 - 2026) Analysis & Trends
Lexicon Pharmaceuticals (LXRX) has reported Change in Inventory for 8 consecutive years, with -$5000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Change in Inventory rose 83.33% year-over-year to -$5000.0; the TTM figure through Mar 2026 stood at $75000.0 (up 123.96% YoY), while the FY2025 annual figure was $50000.0, up 133.33% from the prior year.
- Change in Inventory slipped to -$5000.0 in Q1 2026 per LXRX's latest filing, from $123000.0 in the prior quarter.
- Across five years, Change in Inventory topped out at $172000.0 in Q2 2023 and bottomed at -$405000.0 in Q4 2024.
- Historically, Change in Inventory has averaged $23000.0 across 4 years, with a median of $48000.0 in 2023.
- Annual changes were most pronounced in 2024 — Change in Inventory slumped 1000.0% — and 2025, when it jumped 130.37%.
- Lexicon Pharmaceuticals' Change in Inventory stood at $45000.0 in 2023, then plunged by 1000.0% to -$405000.0 in 2024, then surged by 130.37% to $123000.0 in 2025, then sank by 104.07% to -$5000.0 in 2026.
- Business Quant data shows LXRX's Change in Inventory at -$5000.0 in Q1 2026, $123000.0 in Q4 2025, and -$10000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 27.70 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 28.20 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 47.15 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -2,188.52 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -280,000.00 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 12.97 Mn |
| 10 | Lexicon Pharmaceuticals | 1.04 Bn | 846.13 Mn | 653,000.00 | 920,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 920,000.00 |
| Jun 30, 2026 | 920,000.00 |
| Mar 31, 2026 | -5,000.00 |
| Mar 31, 2026 | -5,000.00 |
| Dec 31, 2025 | 123,000.00 |
| Dec 31, 2025 | 123,000.00 |
| Sep 30, 2025 | -10,000.00 |
| Sep 30, 2025 | -10,000.00 |
| Jun 30, 2025 | -33,000.00 |
| Jun 30, 2025 | -33,000.00 |
| Mar 31, 2025 | -30,000.00 |
| Mar 31, 2025 | -30,000.00 |
| Dec 31, 2024 | -405,000.00 |
| Dec 31, 2024 | -405,000.00 |
| Sep 30, 2024 | 51,000.00 |
| Sep 30, 2024 | 51,000.00 |
| Jun 30, 2024 | 71,000.00 |
| Jun 30, 2024 | 71,000.00 |
| Mar 31, 2024 | 133,000.00 |
| Mar 31, 2024 | 133,000.00 |